Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1982 Sep;196(3):239–245. doi: 10.1097/00000658-198209000-00002

The role of surgery in patients with Zollinger-Ellison syndrome (ZES) managed medically.

M F Brennan, R T Jensen, R A Wesley, J L Doppman, D M McCarthy
PMCID: PMC1352590  PMID: 7114932

Abstract

From 1975 to 1981, the authors' deliberate intent was to treat all patients with Zollinger-Ellison syndrome (ZES) medically. This allowed the authors to ask the question of the need for surgical intervention in patients managed medically. Twenty-six patients followed for an average of 37 months (range 2 to 147 months) from diagnosis were maintained on cimetidine for a mean of 32 months (2 to 64 months). Six of these patients (23%) were unable to be maintained on cimetidine and required surgery during this period. Four received total gastrectomy, and two had lesser operations. Analysis of survival curves in this small group does not illustrate a difference between outcome based on surgical or medical management. Prospective studies based on aggressive attempts at preoperative localization with staging laparotomy and tumor resection seem justified.

Full text

PDF
239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dunnick N. R., Doppman J. L., Mills S. R., McCarthy D. M. Computed tomographic detection of nonbeta pancreatic islet cell tumors. Radiology. 1980 Apr;135(1):117–120. doi: 10.1148/radiology.135.1.6244605. [DOI] [PubMed] [Google Scholar]
  2. ELLISON E. H., WILSON S. D. THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES. Ann Surg. 1964 Sep;160:512–530. doi: 10.1097/00000658-196409000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fox P. S., Hofmann J. W., Decosse J. J., Wilson S. D. The influence of total gastrectomy on survival in malignant Zollinger-Ellison tumors. Ann Surg. 1974 Oct;180(4):558–566. doi: 10.1097/00000658-197410000-00020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fox P. S., Hofmann J. W., Wilson S. D., DeCosse J. J. Surgical management of the Zollinger-Ellison syndrome. Surg Clin North Am. 1974 Apr;54(2):395–407. doi: 10.1016/s0039-6109(16)40287-2. [DOI] [PubMed] [Google Scholar]
  5. Friesen S. R. A gastric factor in the pathogenesis of the Zollinger-Ellison syndrome. Ann Surg. 1968 Sep;168(3):483–501. doi: 10.1097/00000658-196809000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Friesen S. R. Effect of total gastrectomy on the Zollinger-Ellison tumor: observations by second-look procedures. Surgery. 1967 Oct;62(4):609–613. [PubMed] [Google Scholar]
  7. Friesen S. R. Treatment of the Zollinger-Ellison syndrome. A 25 year assessment. Am J Surg. 1982 Mar;143(3):331–338. doi: 10.1016/0002-9610(82)90102-7. [DOI] [PubMed] [Google Scholar]
  8. Ingemansson S., Larsson L. I., Lunderquist A., Stadil F. Pancreatic vein catheterization with gastrin assay in normal patients and in patients with the Zollinger-Ellison syndrome. Am J Surg. 1977 Nov;134(5):558–563. doi: 10.1016/0002-9610(77)90433-0. [DOI] [PubMed] [Google Scholar]
  9. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  10. McCarthy D. M., Hyman P. E. Effect of isopropamide on response to oral cimetidine in patients with Zollinger--Ellison syndrome. Dig Dis Sci. 1982 Apr;27(4):353–359. doi: 10.1007/BF01296756. [DOI] [PubMed] [Google Scholar]
  11. McCarthy D. M., Olinger E. J., May R. J., Long B. W., Gardner J. D. H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy. Ann Intern Med. 1977 Dec;87(6):668–675. doi: 10.7326/0003-4819-87-6-668. [DOI] [PubMed] [Google Scholar]
  12. McCarthy D. M., Peikin S. R., Lopatin R. N., Long B. W., Spiegel A., Marx S., Brennan M. Hyperparathyroidism--a reversible cause of cimetidine-resistant gastric hypersecretion. Br Med J. 1979 Jun 30;1(6180):1765–1766. doi: 10.1136/bmj.1.6180.1765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McCarthy D. M. Report on the United States experience with cimetidine in Zollinger-Ellision syndrome and other hypersecretory states. Gastroenterology. 1978 Feb;74(2 Pt 2):453–458. [PubMed] [Google Scholar]
  14. McCarthy D. M. The place of surgery in the Zollinger-Ellison syndrome. N Engl J Med. 1980 Jun 12;302(24):1344–1347. doi: 10.1056/NEJM198006123022404. [DOI] [PubMed] [Google Scholar]
  15. Passaro E., Jr Localization of pancreatic endocrine tumors by selective portal vein catheterization and radioimmunoassay. Gastroenterology. 1979 Oct;77(4 Pt 1):806–807. [PubMed] [Google Scholar]
  16. Richardson C. T., Feldman M., McClelland R. N., Dickerman R. M., Kumpuris D., Fordtran J. S. Effect of vagotomy in Zollinger-Ellison syndrome. Gastroenterology. 1979 Oct;77(4 Pt 1):682–686. [PubMed] [Google Scholar]
  17. Stadil F., Stage J. G. The Zollinger--Ellison syndrome. Clin Endocrinol Metab. 1979 Jul;8(2):433–446. doi: 10.1016/s0300-595x(79)80051-1. [DOI] [PubMed] [Google Scholar]
  18. ZOLLINGER R. M., ELLISON E. H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg. 1955 Oct;142(4):709-23; discussion, 724-8. [PMC free article] [PubMed] [Google Scholar]
  19. Zollinger R. M., Ellison E. C., Fabri P. J., Johnson J., Sparks J., Carey L. C. Primary peptic ulcerations of the jejunum associated with islet cell tumors. Twenty-five-year appraisal. Ann Surg. 1980 Sep;192(3):422–430. doi: 10.1097/00000658-198009000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES